SynthesisBMC urology2016

Pazopanib as a second-line treatment for non-cytokine-treated metastatic renal cell carcinoma: a meta-analysis of the effect of treatment.

Victor C Kok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.